Clinical trials
Gastrointestinal Neoplasms trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
| Completed | 9 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Abbott Nutrition | 1 |
| Affiliated Hospital of Qinghai University | 1 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| China Medical University, China | 1 |
| Chinese Academy of Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| Feng Tian | 1 |
| Fengh Medical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 29 |
| Stomach Neoplasms | 5 |
| Colorectal Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Digestive System Neoplasms | 2 |
| Frailty | 2 |
| Intestinal Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Malnutrition | 2 |
| Pancreatic Neoplasms | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.